Please enable JavaScript to continue using this application.

Compare $ABSI vs $NTLA | Chartloom

Compare

$ABSI vs $NTLA

Absci Corp · Intellia Therapeutics Inc

ABSI

Absci Corp

NTLA

Intellia Therapeutics Inc

Compare $ABSI vs $NTLA

Comparing Absci Corp and Intellia Therapeutics Inc

ABSIAbsci Corp

NTLAIntellia Therapeutics Inc

ABSIAbsci Corp

Market cap

$1.72B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

486.99x

Rev growth (TTM)

-62.3%

YTD performance

181.4%

52W performance

143.1%

FCF yield

-6.4%

NTLAIntellia Therapeutics Inc

Market cap

$1.83B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

29.07x

Rev growth (TTM)

12.6%

YTD performance

41.9%

52W performance

-46.6%

FCF yield

-19.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABSI

NTLA

Detailed metrics comparison

ABSI

Absci Corp

NTLA

Intellia Therapeutics Inc

Market Cap

ABSI$1.72B

NTLA$1.83B

Enterprise Value

ABSI$1.61B

NTLA$1.72B

Price

ABSI$10.16

NTLA$13.07

P/E Ratio

ABSIN/A

NTLAN/A

P/S Ratio

ABSI1,098.99x

NTLA30.69x

EV/Sales

ABSI1,029.98x

NTLA28.90x

EV/EBITDA

ABSI0.00x

NTLA0.00x

P/B Ratio

ABSI7.72x

NTLA2.36x

P/FCF Ratio

ABSIN/A

NTLAN/A

EV/FCF

ABSI-14.73x

NTLA-4.93x

PEG Ratio

ABSIN/A

NTLAN/A

Forward P/E (NTM)

ABSIN/A

NTLAN/A

Forward P/S (NTM)

ABSI486.99x

NTLA29.07x

Revenue (TTM)

ABSI$2M

NTLA$60M

Revenue Growth (YoY)

ABSI-62.3%

NTLA12.6%

Forward Rev Growth

ABSI359.4%

NTLA80.2%

Gross Margin (TTM)

ABSI0.0%

NTLA0.0%

Operating Margin (TTM)

ABSI0.0%

NTLA0.0%

EBITDA Margin (TTM)

ABSI-7700.6%

NTLA-696.4%

Net Margin (TTM)

ABSI-7756.4%

NTLA-672.2%

FCF Margin (TTM)

ABSI-6994.2%

NTLA-586.0%

Net Income (TTM)

ABSI$-121M

NTLA$-400M

FCF (TTM)

ABSI$-109M

NTLA$-349M

EPS (TTM)

ABSI-$0.77

NTLA-$3.00

ROE (TTM)

ABSI-5921.0%

NTLA-5779.0%

ROA (TTM)

ABSI-5231.0%

NTLA-4729.0%

ROIC (TTM)

ABSI-5901.0%

NTLA-5779.0%

Cash

ABSI$108M

NTLA$106M

Debt

ABSI$150K

NTLA$0

Net Cash/Debt

ABSI$108M

NTLA$106M

Current Ratio (TTM)

ABSI10.63x

NTLA6.65x

Quick Ratio (TTM)

ABSI10.26x

NTLA5.61x

Debt/Equity (TTM)

ABSI0.00x

NTLA0.00x

Debt/Assets (TTM)

ABSI0.0%

NTLA0.0%

Interest Coverage (TTM)

ABSIN/A

NTLAN/A

Net Debt/EBITDA (TTM)

ABSI0.00x

NTLA0.00x

Beta

ABSI2.17

NTLA1.83

52W Performance

ABSI143.1%

NTLA-46.6%

YTD Performance

ABSI181.4%

NTLA41.9%

% from 52W High

ABSI-15.7%

NTLA-53.7%

% from 52W Low

ABSI353.6%

NTLA64.4%

Asset Turnover (TTM)

ABSI0.01x

NTLA0.07x

FCF Yield (TTM)

ABSI-6.4%

NTLA-19.1%

Earnings Yield (TTM)

ABSI-7.1%

NTLA-21.9%

Dividend Yield (TTM)

ABSIN/A

NTLAN/A

Rule of 40

ABSI-7,056.5

NTLA-573.4

EV/GP/RG

ABSIN/A

NTLAN/A

Ticker research

View ABSI research View NTLA research

Metric	ABSI Absci Corp	NTLA Intellia Therapeutics Inc
Market & Valuation
Market Cap	$1.72B	$1.83B
Enterprise Value	$1.61B	$1.72B
Price	$10.16	$13.07
P/E Ratio	N/A	N/A
P/S Ratio	1,098.99x	30.69x
EV/Sales	1,029.98x	28.90x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.72x	2.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-14.73x	-4.93x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	486.99x	29.07x
Revenue & Growth
Revenue (TTM)	$2M	$60M
Revenue Growth (YoY)	-62.3%	12.6%
Forward Rev Growth	359.4%	80.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7700.6%	-696.4%
Net Margin (TTM)	-7756.4%	-672.2%
FCF Margin (TTM)	-6994.2%	-586.0%
Net Income (TTM)	$-121M	$-400M
FCF (TTM)	$-109M	$-349M
EPS (TTM)	-$0.77	-$3.00
ROE (TTM)	-5921.0%	-5779.0%
ROA (TTM)	-5231.0%	-4729.0%
ROIC (TTM)	-5901.0%	-5779.0%
Financial Health
Cash	$108M	$106M
Debt	$150K	$0
Net Cash/Debt	$108M	$106M
Current Ratio (TTM)	10.63x	6.65x
Quick Ratio (TTM)	10.26x	5.61x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.17	1.83
52W Performance	143.1%	-46.6%
YTD Performance	181.4%	41.9%
% from 52W High	-15.7%	-53.7%
% from 52W Low	353.6%	64.4%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.07x
FCF Yield (TTM)	-6.4%	-19.1%
Earnings Yield (TTM)	-7.1%	-21.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-7,056.5	-573.4
EV/GP/RG	N/A	N/A
Ticker research	View ABSI research	View NTLA research

Valuation

P/S Ratio

NTLA

30.69x

ABSI

1,098.99x

EV/FCF

ABSI

-14.73x

NTLA

-4.93x

Growth & revenue

Revenue Growth TTM

NTLA

12.6%

ABSI

-62.3%

Forward Revenue Growth

ABSI

359.4%

NTLA

80.2%

Profitability & performance

Gross Margin

ABSI

0.0%

NTLA

0.0%

ROE

NTLA

-5779.0%

ABSI

-5921.0%

FCF Yield %

ABSI

-6.4%

NTLA

-19.1%

52-Week Performance

ABSI

143.1%

NTLA

-46.6%

Detailed metrics comparison

ABSI

Absci Corp

NTLA

Intellia Therapeutics Inc

Market Cap

ABSI$1.72B

NTLA$1.83B

Enterprise Value

ABSI$1.61B

NTLA$1.72B

Price

ABSI$10.16

NTLA$13.07

P/E Ratio

ABSIN/A

NTLAN/A

P/S Ratio

ABSI1,098.99x

NTLA30.69x

EV/Sales

ABSI1,029.98x

NTLA28.90x

EV/EBITDA

ABSI0.00x

NTLA0.00x

P/B Ratio

ABSI7.72x

NTLA2.36x

P/FCF Ratio

ABSIN/A

NTLAN/A

EV/FCF

ABSI-14.73x

NTLA-4.93x

PEG Ratio

ABSIN/A

NTLAN/A

Forward P/E (NTM)

ABSIN/A

NTLAN/A

Forward P/S (NTM)

ABSI486.99x

NTLA29.07x

Revenue (TTM)

ABSI$2M

NTLA$60M

Revenue Growth (YoY)

ABSI-62.3%

NTLA12.6%

Forward Rev Growth

ABSI359.4%

NTLA80.2%

Gross Margin (TTM)

ABSI0.0%

NTLA0.0%

Operating Margin (TTM)

ABSI0.0%

NTLA0.0%

EBITDA Margin (TTM)

ABSI-7700.6%

NTLA-696.4%

Net Margin (TTM)

ABSI-7756.4%

NTLA-672.2%

FCF Margin (TTM)

ABSI-6994.2%

NTLA-586.0%

Net Income (TTM)

ABSI$-121M

NTLA$-400M

FCF (TTM)

ABSI$-109M

NTLA$-349M

EPS (TTM)

ABSI-$0.77

NTLA-$3.00

ROE (TTM)

ABSI-5921.0%

NTLA-5779.0%

ROA (TTM)

ABSI-5231.0%

NTLA-4729.0%

ROIC (TTM)

ABSI-5901.0%

NTLA-5779.0%

Cash

ABSI$108M

NTLA$106M

Debt

ABSI$150K

NTLA$0

Net Cash/Debt

ABSI$108M

NTLA$106M

Current Ratio (TTM)

ABSI10.63x

NTLA6.65x

Quick Ratio (TTM)

ABSI10.26x

NTLA5.61x

Debt/Equity (TTM)

ABSI0.00x

NTLA0.00x

Debt/Assets (TTM)

ABSI0.0%

NTLA0.0%

Interest Coverage (TTM)

ABSIN/A

NTLAN/A

Net Debt/EBITDA (TTM)

ABSI0.00x

NTLA0.00x

Beta

ABSI2.17

NTLA1.83

52W Performance

ABSI143.1%

NTLA-46.6%

YTD Performance

ABSI181.4%

NTLA41.9%

% from 52W High

ABSI-15.7%

NTLA-53.7%

% from 52W Low

ABSI353.6%

NTLA64.4%

Asset Turnover (TTM)

ABSI0.01x

NTLA0.07x

FCF Yield (TTM)

ABSI-6.4%

NTLA-19.1%

Earnings Yield (TTM)

ABSI-7.1%

NTLA-21.9%

Dividend Yield (TTM)

ABSIN/A

NTLAN/A

Rule of 40

ABSI-7,056.5

NTLA-573.4

EV/GP/RG

ABSIN/A

NTLAN/A

Ticker research

View ABSI research View NTLA research

Metric	ABSI Absci Corp	NTLA Intellia Therapeutics Inc
Market & Valuation
Market Cap	$1.72B	$1.83B
Enterprise Value	$1.61B	$1.72B
Price	$10.16	$13.07
P/E Ratio	N/A	N/A
P/S Ratio	1,098.99x	30.69x
EV/Sales	1,029.98x	28.90x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.72x	2.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-14.73x	-4.93x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	486.99x	29.07x
Revenue & Growth
Revenue (TTM)	$2M	$60M
Revenue Growth (YoY)	-62.3%	12.6%
Forward Rev Growth	359.4%	80.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7700.6%	-696.4%
Net Margin (TTM)	-7756.4%	-672.2%
FCF Margin (TTM)	-6994.2%	-586.0%
Net Income (TTM)	$-121M	$-400M
FCF (TTM)	$-109M	$-349M
EPS (TTM)	-$0.77	-$3.00
ROE (TTM)	-5921.0%	-5779.0%
ROA (TTM)	-5231.0%	-4729.0%
ROIC (TTM)	-5901.0%	-5779.0%
Financial Health
Cash	$108M	$106M
Debt	$150K	$0
Net Cash/Debt	$108M	$106M
Current Ratio (TTM)	10.63x	6.65x
Quick Ratio (TTM)	10.26x	5.61x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.17	1.83
52W Performance	143.1%	-46.6%
YTD Performance	181.4%	41.9%
% from 52W High	-15.7%	-53.7%
% from 52W Low	353.6%	64.4%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.07x
FCF Yield (TTM)	-6.4%	-19.1%
Earnings Yield (TTM)	-7.1%	-21.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-7,056.5	-573.4
EV/GP/RG	N/A	N/A
Ticker research	View ABSI research	View NTLA research